For the Quarter Ending December 2022
In the fourth quarter of 2022, the Acebutolol API market in North America experienced a fluctuating trend. Prices began to climb in Q4 2022 and continued to do so throughout the second month of the fourth quarter due to high manufacturing costs, numerous logistical issues, and rising inflation. The US inflation Soar to 8.2% in the month of October 2022. Additionally contributing to the price fluctuation were rising transportation costs and port congestion at the major ports. However, Prices begin to decline later in the month of December as a result of weaker inflation (the US inflation rate was 7%, down from 8.2% in October) and decreased end-user sector demand as the holiday season approaches. The Acebutolol API settlement price in December fell to USD 95336/MT CFR Los Angeles.
The Asia Pacific Acebutolol API market saw a turbulent fourth quarter in 2022. It was witnessed that the prices rose considerably till the second month of the quarter due to increased end-user sector demand, several logistical challenges, and rising inflation. The Producer Price Index (PPI) grew by 0.9% while the Consumer Price Index in China increased by 2.8%, both of which had an impact on the market. The "Zero-Covid" policy in China has so far impacted investor confidence and the nation's economic operations. The market remained competitive because of rising production costs brought on by rising energy prices as well as increased domestic output to meet demands from both domestic and foreign markets. Later in December, as domestic merchants had sufficient stock, Acebutolol API prices began to decline. The policies being relaxed and the weak downstream demand influenced the market's ongoing decline. In December, the settlement price for Acebutolol API fell to USD 93590/MT FOB Shanghai.
In the fourth quarter of 2022, prices for Acebutolol API showcased a soaring trajectory in the European region. The downstream market for the pharmaceutical sector was seen to have a steady demand for Acebutolol API. Price hikes were brought on by ongoing port congestion and supply disruption in the European region throughout Q4 022. Also, the European annual inflation rate was 10.6% in Q4 2022, up from 9.9%. Retailers in Europe make the decision to refill their inventory due to the approaching Christmas season considerably. Also, to ease the inflationary pressure, the market players were propelled to raise their quotations in order to slow down the demand and consumer consumption. The cost of Acebutolol API was USD 100270/MT CFR Hamburg toward the end of Q4 2022.
For the Quarter Ending September 2022
The price trends of Acebutolol have witnessed declining market dynamics in the third quarter of 2022. The hampered trade activities across the globe have severely influenced the price chain of Acebutolol in the regional market. The rising inflation has further supported Acebutolol's depleting market values among traders due to lowering demand from the end-user industry. At the termination of Q3 2022, the cost accessed at USD 101020/MT with an average quarterly declination of 2.14%. In addition, lower production and input costs drove Acebutolol costs lower across the regional market throughout the third quarter.
During the third quarter of 2022, the Acebutolol market witnessed plunging behavior in the Asia- Pacific region. The Acebutolol prices depreciate throughout the quarter due to lackluster demand from the terminal pharmaceutical sector. Also, the slowed economy, sufficient supplies, and enough inventories supported this downward price trend. Weak demand fundamentals and regular supply led the Acebutolol market to continue its downward trend. Towards the end of the second half of Q3, prices significantly escalated amid the increased inquiries from the domestic and international markets. Also, hampered supply owing to former production halts and trade activities following extreme weather in Condon and zero covid policies affected the market in the last month. At the termination of Q2 2022, the values accessed at USD 91080/MT with an average quarterly declination of 1.45%.
The Acebutolol market has truncated in the third quarter of 2022 amid poor demand dynamics from the downstream pharmaceutical sector. At the termination of Q3 2022, the values accessed at USD 104800/MT with an average quarterly declination of 3.21%. The plunging values have also been triggered by decreasing offtakes from the regional market, which led to a muted trading dynamic. The end-user supplier and traders were bargaining over their existing stockpiled goods to maintain their profit margins. Operating costs and raw material prices continued to decline, and purchasing activities fell somewhat. All these variables influenced the dwindling market dynamics with a negative price movement for Acebutolol.
The price trends of Acebutolol have witnessed inclining market sentiments in the second quarter of 2022. The COVID-19 resurgence and hampered trade activities across the globe have severely hampered the price value chain of Acebutolol in the regional market. The raging inflation and soaring energy costs have further supported Acebutolol's escalated market values among the traders. Furthermore, constrained imported cargo flow pressurized the margin among the downstream pharmaceutical ventures affecting the sales and revenues. At the termination of Q2 2022, the values accessed at USD 108000/MT with the average quarterly inclination of 2.90%. The finished drug market also remained affected by surging demand from end consumers. In addition, Logistical issues and a scarcity of containers drove higher Acebutolol costs across the regional market throughout the second quarter.
During the second quarter of 2022, the price trends of Acebutolol oscillated in the Asia- Pacific region. The prices improved throughout the quarter due to active demand from the terminal sector. The acebutolol market continues its uptrend in the Indian domestic market owing to speculations around the global supply chains and strong demand fundamentals. The prices have significantly escalated since the beginning of second quarter amid the increased inquiries from domestic and international market players. Furthermore, the hampered trade activities in China have also provoked the limited availability of the products for the importing countries. As supply-side concerns escalated in the region, the manufacturers corrected their quotations in the second quarter. At the termination of Q2 2022, the values accessed at USD 95220/MT with the average quarterly inclination of 1.94%.
The Acebutolol market has expanded in the second quarter amid robust demand from downstream pharmaceutical companies. The active covid cases and global supply turmoil unleashed by Russia’s invasion of Ukraine have severely impacted the market sentiments of Acebutolol in the regional market. The volatility in energy costs has also exerted enough cost pressure on the market value of Acebutolol in the regional market. The domestic manufacturers have increased their production capacities to meet the demand from the downstream pharmaceutical firms. At the termination of Q2 2022, the values accessed at USD 115860/MT with the average quarterly inclination of 1.66%. Furthermore, the limited availability of Chinese supplies amid the stringent lockdown measures has pressurized the price dynamics of Acebutolol throughout the second quarter.